
Molnupiravir - Covid-19
You are here : Home > Formulary Search > Molnupiravir - Covid-19
I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.
Status 1
Red
Formulations :
- Not Specified
Formulary Status :
Restrictions / Comments :
Important
Primary care and outpatient prescribing of antivirals for COVID 19 treatment is through the CMDU service
Status 2
Red
Formulations :
- Not Specified
Formulary Status :
Restrictions / Comments :
Important
Primary care and outpatient prescribing of antivirals for COVID 19 treatment is through the CMDU service
Documents :
Documentation
- No records returned.
PAD Profile
ChemicalSubstance :
Molnupiravir
Indication :
Covid-19
Group Name :
Keywords :
Covid 19, Coronavirus, antivirals
Brand Names Include :
Lagevrio
Important Information :
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
1
Traffic Light Entries :
2
Other Indications
Below are listed other indications that Molnupiravir is used to treat.
- No records returned.
Other Drugs
Below are listed other drugs that are used to treat Covid-19.
Committee Recommendations (1)
DO NOT prescribe in primary care.
This drug is recommended in the treatment of COVID-19 ONLY in line with NHSE commissioning policies which include detail on eligibility and exclusion criteria for:
- Non-hospitalised patients - Refer eligible patients from Surrey Heartlands and Frimley to the East Berkshire Primary Care Covid Medicine Delivery Unit.
- Hospitalised patients – Hospital treatment of those with acute Covid-19 illness OR with hospital onset Covid-19